Pfizer CEO Albert Burla Announces $43 Billion Acquisition of Seagen Cancer Biotechnology
Pfizer CEO Albert Burla Announces $43 Billion Acquisition of Seagen Cancer Biotechnology
“1 in 3 people in the world will get cancer in their lifetime… It's kind of like mRNA for vaccines, [but] it's for cancer treatment. Therefore, we think that with this technology in our hands, we can achieve very great results and bring relief to the whole world. On a scale never seen before due to this devastating disease, wow. And you also expect that it could generate about $10 billion in revenue for Pfizer by 20-30 years, contributing to the overall goal.”
The key word here is yield. They first increased the risk of cancer for everyone who underwent gene therapy, and now they want to save everyone again with another very profitable mRNA-like technology. Well, what a fabulous ....
-
2:53
AMERICAXPOSED
1 year agoPfizer CEO Albert Bourla Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion
208 -
2:38
Asher Press
1 year agoPfizer CEO Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion
170 -
2:38
Now Trending w/ Wall Street Apes
1 year agoPfizer CEO Announces Acquisition of Cancer Treatment Biotech Seagen
1.39K -
2:38
RedpillUSAPatriots
1 year agoPfizer CEO Albert Bourla Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion
2.2K13 -
2:40
Uncensored Storm
1 year agoPfizer Acquires Cancer Treatment Biotech Seagen for $43B
7319 -
2:38
alexlunaviewer
1 year agoPfizer CEO Albert Bourla Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion
2511 -
2:38
galacticstorm
1 year agoPfizer Acquires Cancer Treatment Biotech Seagen For $43 Billion
38 -
2:38
jess93
4 months agoEmpire PFIZER Bought Seagen Cancer for $43 Billion CEO Bourla Ready to Cash Billions$: He Said 1 out 3 People Globally Will Have Cancer
96 -
2:38
Rolling With You
1 year agoPfizer Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion.
46 -
2:38
Chief Nerd
1 year agoNEW — Pfizer Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion
5.64K12